Today the cost of developing new drug is around 2.6 billion dollars and it takes almost 15 years for a successful molecule to hit the market. Our research is focused to change this dynamics. We bring cutting edge in-silico tools to market through incorporating novel mathematical concepts into simple and testable modeling platforms. Currently there are 1200 FDA approved FDA drugs designed to target 400-600 proteins of presumed 100,000 functionally distinct proteins in the human interacome. This indicates there are likely to be a large number of potential drug targets that need to be identified. Our In-silico research portfolio is designed to discover and develop these targets.
